Owner YAMANOUCHI PHARMACEUTICAL CO., LTD.

Inventors NAKATOU, Kazuhiro; KUBOTA, Hideki; SUZUKI, Takeshi; MIURA, Masanori; NAKAI, Eiichi; YAHIRO, Kiyoshi; MIYAKE, Akira; MOCHIZUKI, Shinobu

Pub. Number AU-A-2003244463

PCT Number PCT/JP03/01065

PCT Pub. Number WO2003/066099

Priority 2002-28844 05.02.02 JP

Filing date 3 February 2003

Wipo publication date 2 September 2003

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 251/70 Heterocyclic compounds containing 1,3,5-triazine rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 031/53 - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 025/28 Drugs for disorders of the nervous system